CIK 0001822462 · Non-accelerated filer<br>Smaller reporting company
Foghorn Therapeutics Inc.
Sign in to watch- Ticker
- FHTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-586-3100
- Business address
- 500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, 02139
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- UPLOAD Other SEC-generated Letter
- 8-K Event Executive or director change
- 4 Option exercise Chief Scientific Officer acquired 1,858 shares (option exercise)
- 10-Q Report Quarterly Report
- 10-K/A Report 10-K/A
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-Q/A Report 10-Q/A
- UPLOAD Other SEC-generated Letter
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 18 · 356 filings